Overview

Vortioxetine in Patients With Depression and Early Dementia

Status:
Recruiting
Trial end date:
2022-04-02
Target enrollment:
Participant gender:
Summary
This study evaluates the effectiveness of vortioxetine on depressive symptoms in patients with depression and early dementia
Phase:
Phase 4
Details
Lead Sponsor:
H. Lundbeck A/S
Collaborator:
ICON plc
Treatments:
Vortioxetine